Suggestions
Emily Chang
CDx and Commercial Project Management at Precision For Medicine
Emily Chang is a highly motivated and accomplished leader in the development of in vitro diagnostics, specializing in companion diagnostics for gene therapy products and next-generation sequencing (NGS)-based tissue and liquid biopsy diagnostics.
She possesses extensive experience in design control processes from proof-of-concept stages through product launch, including verification and validation studies, clinical trials, and FDA IDE/510(k)/PMA submissions.
Emily excels in risk management, project management, leading large cross-functional teams, and is PMP-certified with exceptional planning and organizational skills to successfully deliver complex projects within challenging timelines.
Her educational background includes a Doctor of Philosophy (Ph.D.) and a Master of Science (M.S.) in Chemical Engineering from Massachusetts Institute of Technology, as well as a Bachelor of Science (B.S.) in Chemical and Biomolecular Engineering from the University of Pennsylvania.
She is affiliated with the prestigious Massachusetts Institute of Technology.
